drugset / Trial / NCT00229697
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being carried out to see if ZD1839 is effective in treating metastatic breast cancer in combination with Nolvadex, and if so, how it compares with Nolvadex alone.
Timeline
- Start
- 2003-10
- Primary completion
- 2006-12
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | 250 mg | — |
| Background | Tamoxifen | Small molecule | 20 mg | — |